Physician profile
Kathleen Phan
NPI 1427617505
$996.52
in general payments reported to CMS, 2019-2025
8 companies · $493 in 2025
The $493 reported for 2025 was more than what 77% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $86.67 · 2021: $48.10 · 2023: $177 · 2024: $192 · 2025: $493.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $862.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $861.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $250.05 | 2023-2024 | Acuvue |
| Bausch & Lomb Americas INC. | $240.17 | 2024-2025 | Miebo, Xiidra |
| Glaukos Corporation | $227.09 | 2025 | Photrexa Viscous and Photrexa |
| Dompe US, INC. | $120.27 | 2025 | Oxervate |
| Carl Zeiss Meditec, INC. | $86.67 | 2019 | |
| Abb Con-Cise Optical Group LLC | $24.81 | 2021 | |
| Biotissue Holdings INC. | $24.17 | 2025 | |
| Alcon Vision LLC | $23.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathleen Phan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.